SNM/Nihon Medi-Physics sponsor new fellowship program for Japanese physicians

November 07, 2007

RESTON, Va.--SNM, the world's largest molecular imaging and nuclear medicine society, recently announced a new, two-year $24,000 fellowship program in the United States for Japanese physicians in the early stages of their career.

"The SNM Wagner-Torizuka Fellowship will advance fellows' research and clinical experience, as well as facilitate professional development, so young Japanese physicians can make significant contributions to the field of molecular imaging and nuclear medicine," said SNM President Alexander J. McEwan. "With this new program, SNM continues its long-time tradition of promoting--and expanding--the discovery of new science and the creation of new techniques and technologies," added the professor and chair of the Department of Oncology, Faculty of Medicine, at the University of Alberta, and director of oncologic imaging at Cross Cancer Institute in Edmonton, Canada. "SNM is especially grateful to Nihon Medi-Physics, a Japanese diagnostic nuclear medicine firm, and SNM members Henry N. Wagner Jr. and Kanji Torizuka for sponsoring the fellowship," said McEwan. This fellowship encourages Japanese physicians to enhance international research and clinical collaboration with their American colleagues in molecular imaging and nuclear medicine and enhances cooperation between SNM and the Japanese Society of Nuclear Medicine (JSNM), he added.

"For almost half a century, Japanese physicians and scientists have studied nuclear medicine in the United States. Scores of them founded and now head departments of nuclear medicine and radiology in Japan," said Wagner, professor emeritus of medicine and radiology at Johns Hopkins Medical Institutions, Baltimore, Md. "This fellowship is a step toward ensuring that this outstanding relationship will continue far into the future of this exciting, new, revolutionary specialty of molecular imaging," he added. The fellowship will help assist Japanese physicians in becoming the new leaders of molecular imaging and nuclear medicine in cardiology, oncology, neurology, radiology and other specialties, said Wagner.

"This program will greatly contribute to the further progress of molecular imaging and nuclear medicine in Japan," noted Torizuka, emeritus professor of Kyoto University and Fukui Medical University. "Young Japanese physicians will have invaluable experiences in the United States through this wonderful program. They can then lead the exciting new era of molecular imaging and nuclear medicine in Japan, maintaining collaboration and friendship with colleagues in the United States," he added.

Eligible recipients must be permanent residents of Japan, receiving their Japanese medical license within the past 15 years. To learn more, visit SNM's Web site at http:www.snm.org/fellowships or contact Nicole Kern, SNM program manager, via e-mail at nkern@snm.org or by phone at (703) 652-6795.
-end-
About SNM--Advancing Molecular Imaging and TherapySNM is an international scientific and professional organization of more than 16,000 members dedicated to promoting the science, technology and practical applications of molecular and nuclear imaging to diagnose, manage and treat diseases in women, men and children. Founded more than 50 years ago, SNM continues to provide essential resources for health care practitioners and patients; publish the most prominent peer-reviewed journal in the field (the Journal of Nuclear Medicine); host the premier annual meeting for medical imaging; sponsor research grants, fellowships and awards; and train physicians, technologists, scientists, physicists, chemists and radiopharmacists in state-of-the-art imaging procedures and advances. SNM members have introduced--and continue to explore--biological and technological innovations in medicine that noninvasively investigate the molecular basis of diseases, benefiting countless generations of patients. SNM is based in Reston, Va.; additional information can be found online at http://www.snm.org.

Society of Nuclear Medicine

Related Molecular Imaging Articles from Brightsurf:

New technique offers higher resolution molecular imaging and analysis
The new approach from Northwestern Engineering could help researchers understand more complicated biomolecular interactions and characterize cells and diseases at the single-molecule level.

Molecular imaging offers insight into therapy outcomes for neuroendocrine tumor patients
A new proof-of-concept study published in the May issue of The Journal of Nuclear Medicine has demonstrated that molecular imaging can be used for identifying early response to 177Lu-DOTATATE treatment in neuroendocrine tumor patients.

Non-invasive imaging method spots cancer at the molecular level
Researchers for the first time have combined a powerful microscopy technique with automated image analysis algorithms to distinguish between healthy and metastatic cancerous tissue without relying on invasive biopsies or the use of a contrast dye.

Molecular imaging suggests smokers may have impaired neuroimmune function
Research presented at the 2019 Annual Meeting of the Society of Nuclear Medicine and Molecular Imaging (SNM MI) shows preliminary evidence that tobacco smokers may have reduced neuroimmune function compared with nonsmokers.

Novel noninvasive molecular imaging for monitoring rheumatoid arthritis
A first-in-human Phase 1/Phase II study demonstrates that intravenous administration of the radiopharmaceutical imaging agent technetium-99m (99mTc) tilmanocept promises to be a safe, well-tolerated, noninvasive means of monitoring rheumatoid arthritis disease activity.

Improving molecular imaging using a deep learning approach
Generating comprehensive molecular images of organs and tumors in living organisms can be performed at ultra-fast speed using a new deep learning approach to image reconstruction developed by researchers at Rensselaer Polytechnic Institute.

Nanoplatform developed with three molecular imaging modalities for tumor diagnosis
Nanotechnology and biotechnology are bringing us increasingly closer to personalised cancer treatment.

Study suggests molecular imaging strategy for determining molecular classifications of NSCLC
Recent findings suggest a novel positron emission tomography (PET) imaging approach determining epidermal growth factor receptor (EGFR) mutation status for improved lung cancer patient management.

New imaging technique able to watch molecular dynamics of neurodegenerative diseases
Researchers have developed a fast and practical molecular-scale imaging technique that could let scientists view never-before-seen dynamics of biological processes involved in neurodegenerative diseases such as Alzheimer's disease and multiple sclerosis.

Combined optical and molecular imaging could guide breast-conserving surgery
Breast-conserving surgery is the primary treatment for early-stage breast cancer, but more accurate techniques are needed to assess resection margins during surgery to avoid the need for follow-up surgeries.

Read More: Molecular Imaging News and Molecular Imaging Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.